HOME >> MEDICINE >> NEWS
Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy

(PHILADELPHIA) -- The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, the researchers say.

The team of scientists including first author Jose Moreno, M.D., clinical associate professor of urology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and the Kimmel Cancer Center at Jefferson looked at circulating tumor cells (CTCs) in 240 men with metastatic prostate cancer that failed hormone-depletion therapy. They compared levels prior to chemotherapy and after two to five weeks of treatment. They found that those men with more than five tumor cells per blood sample had a worse prognosis than those who had fewer cells. One half of the patients with more than five CTCs lived at least 10 months, whereas half of the men with fewer tumor cells lived substantially longer 21 months.

Dr. Moreno presents the trials findings June 4, 2007 at the annual meeting of the American Society of Clinical Oncology in Chicago.

The results of the 65-site trial also showed that those patients who underwent chemotherapy and whose CTC number went down fared better and had a more favorable prognosis. That is, the level of response to chemotherapy was reflected in the CTC level, notes Dr. Moreno. The numbers held up even after up to 20 weeks of treatment. If chemotherapy doesnt reduce the CTC level, its information that enables the physician to change the drug regimen or perhaps stop treatment, he says.

Dr. Moreno notes that the prostate specific antigen has been a powerful biomarker for cancer presence and a useful way to gauge treatment effectiveness for years, though it has some flaws. He thinks that th
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
4-Jun-2007


Page: 1 2

Related medicine news :

1. Trial stops after stroke and mortality significantly reduced by blood
2. Trials underway for essential new TB vaccine
3. ENDEAVOR III Trial reports key findings on new-generation stent
4. NIH names Clinical Trial Units for the Microbicide Trials Network
5. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
6. The Public Library of Science launches the new open access journal PLoS Clinical Trials
7. Trial shows vaccine against cervical cancer provides long-term protection
8. Trial shows malaria vaccine could protect young children from disease for 18 months
9. Trial demonstrates new drugs effectiveness against psoriasis
10. Trial at Jefferson shows new drug may help cancer patients who need stem cell transplants
11. Second implant of US Pilot Trial achieved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... As part of August’s Children’s Eye Health ... for Children’s Vision and Eye Health at Prevent Blindness (NCCVEH) has released an updated ... National Issues 2nd Edition . The goal of the report is , ...
(Date:7/18/2020)... ... , ... A June 2 article on Daily Mail reported on a fitness model ... augmentations. The article says that her first procedure, unbeknownst to her, was performed by a ... surgeon to revise her procedure, only to find out the doctor did not have the ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... life, Isagenix International is evolving its brand. While the global company ... holistic approach that supports physical, emotional, and spiritual wellbeing. The company announced the ...
(Date:7/10/2020)... ... July 10, 2020 , ... Health and beauty medical ... Liposuction 360 . The group, with offices located throughout Greater Los Angeles ... surgeries and cosmetic procedures is an exciting new addition to the list of ...
(Date:7/10/2020)... ... July 10, 2020 , ... NeoTract, ... in the field of urology, today announced that Carl Meyer, M.D., The Iowa ... of Excellence. The designation recognizes that Dr. Meyer has achieved a high level ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... ... As one of the most prominent and popular Houston area dental practices, ... a wide range of professional dental services for many years. The recently opened office ... far from the previous clinic location. Dr. Simone Ellis’s modern, cutting-edge dental clinic is ...
(Date:7/22/2020)... (PRWEB) , ... July 22, 2020 , ... ... management technology, is proud to announce the addition of Moderna to its growing ... who rely on its technology for trial disclosure management, patient engagement and study ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... Psychiatry uses case scenarios to illustrate how implicit bias among psychiatrists and other ... to sexual and gender minority people. The Perspective was authored by researchers at ...
Breaking Medicine Technology:
Cached News: